Tweets
almost half PsA patients have 3 pr more co-morbidities and 67% of those surveyed do not think rheumos should not manage them - when did we stop being physicians ? @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
« difficult to treat PsA » how mich combination obesity, non-inflammatory MSK pain, fibromyalgia and depression making assessment tricky and risk of rattling through therapies fast! @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
Dr. D Aletaha defines The #EULARManifesto, "It is about patient centeredness-- improving quality of care, advocating for patients, timely access to specialists, pushing R&D innovation, integrating technology to make sure every patient gets the care they need." @rheumnow #EULAR24
TheDaoIndex @KDAO2011 ( View Tweet )
1 year 8 months ago
🌎 Global disparities in steroid prescribing in #SLE
💊 HCQ assoc with decreased steroid use
📈 Other contributing factors may be prevalence, severity & phenotype of disease, plus access to DMARDs & biologics
📍SLE poster tour 15:30 TODAY
#EULAR2024
Abs #POS0013
@RheumNow https://t.co/7pL8kpeqOs
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 8 months ago
LBA0001 (2024)
EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
- looking good, nice results @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
LONG-TERM EFFICACY TOCILIZUMAB AFTER ULTRA-SHORT GC TO TREAT GCA: 3 Yr FOLLOW-UP OF THE GUSTO TRIAL
3 day GC pulse immediate 12 mths Toci 85% drug free remission at 4 yrs! @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
RISK OF PsA IN PATIENTS WITH PsO UNDERGOING bDMARDs GLOBAL POPULATION STUDY (TRINETX)
870,000 PsO pts without PsA treated with bDMARDS - Il12/23i and Il23i. 30-37% lower PsA developed than comparators @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
OP0031 (2024)
COMPARATIVE ANALYSIS OF TNF INHIBITORS AND IL17 INHIBITORS IN PSORIATIC ARTHRITIS: EXPLORING CARDIOVASCULAR OUTCOMES signif absolute risk difference 3 % ischaemic heart disease 2 % heart failure TNFi vs IL17i @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
And were are on folks!! 🎙️
Delighted to join @RheumNow faculty again this year
I will be covering RA and PsA topics during #EULAR2024
Don’t miss our Daily recaps live 6pm
Oh and if you see me around, come and say Hi! https://t.co/TrQ9b3WeSy
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 8 months ago
Grappa difficult to treat PsA meeting - SLR, Patient & rheumo survey, definition eg - fail 1 csDMARD & 2 bDMARDs different MOA - names matter suggest ditch « difficult » for « refractory » @rheumnow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 8 months ago
Australian studyshows knee OA pts unconsciously believe that activity may be dangerous to their condition, despite medical advice telling them otherwise. 69% of people with knee pain had stronger implicit (unconscious) beliefs that exercise was dangerous https://t.co/iytfpcGvD8 https://t.co/N183ffYfPP
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 year 8 months ago
#EULAR2024 Opening Ceremony. @DanielAletaha highlighted values of @eular strategies that have been achieved:
Patient centredness ✔️
Innovation ✔️ - RheumaFacts, ENTRI, Exams
Inclusivity ✔️
To strive on 3 other values by next year under President-Elect @XBaraliakos @RheumNow https://t.co/wDR2vtv3I2
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 8 months ago
